Factor XII: form determines function
- PMID: 27282310
- DOI: 10.1111/jth.13383
Factor XII: form determines function
Abstract
Factor XII is a mysterious plasma protein without a clear physiologic function. It was identified as a clotting factor, but has no clear role in hemostasis. However, FXII also contributes to the production of bradykinin, a short-lived inflammatory peptide. A growing body of mechanistic research from animal models indicates that FXII contributes to thrombotic disease by triggering excessive coagulation. FXII is evolutionarily conserved, suggesting that this molecule does have a physiologic function. This leads to intriguing questions: What does FXII really do? Is it even a real clotting factor at all? Before the groundbreaking discovery of a role for FXII in thrombotic disease, many studies investigated the biochemical properties of FXII and its activators. In this review, we highlight several biochemical studies that reveal much about the natural behavior of FXII. On the basis of these findings, it is possible to draft a conceptual model to explain how FXII reacts to surface materials. We then discuss how this model applies to the activities of FXII in its natural environment. There are two tentative physiologic functions of FXII that can operate exclusively: (i) maintenance of thrombus stability; (ii) local regulation of vascular permeability. Either, or both, of these natural functions may explain the evolutionary development and maintenance of FXII.
Keywords: blood coagulation; bradykinin; factor XII; plasmin; prekallikrein.
© 2016 International Society on Thrombosis and Haemostasis.
Similar articles
-
The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.J Thromb Haemost. 2016 Jan;14(1):28-39. doi: 10.1111/jth.13194. Epub 2016 Jan 11. J Thromb Haemost. 2016. PMID: 26565070 Review.
-
Factor XII in coagulation, inflammation and beyond.Cell Signal. 2018 Nov;51:257-265. doi: 10.1016/j.cellsig.2018.08.006. Epub 2018 Aug 15. Cell Signal. 2018. PMID: 30118759 Review.
-
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.J Exp Med. 2006 Mar 20;203(3):513-8. doi: 10.1084/jem.20052458. Epub 2006 Mar 13. J Exp Med. 2006. PMID: 16533887 Free PMC article.
-
Plasma levels of bradykinin are suppressed in factor XII-deficient mice.Thromb Haemost. 2006 Jun;95(6):1003-10. doi: 10.1160/TH06-03-0128. Thromb Haemost. 2006. PMID: 16732380
-
Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.Thromb Res. 2010 Mar;125(3):210-5. doi: 10.1016/j.thromres.2009.11.028. Thromb Res. 2010. PMID: 20022081 Free PMC article. Review.
Cited by
-
Protease activity in single-chain prekallikrein.Blood. 2020 Feb 20;135(8):558-567. doi: 10.1182/blood.2019002224. Blood. 2020. PMID: 31800958 Free PMC article.
-
Factor XII Structure-Function Relationships.Semin Thromb Hemost. 2024 Oct;50(7):937-952. doi: 10.1055/s-0043-1769509. Epub 2023 Jun 5. Semin Thromb Hemost. 2024. PMID: 37276883 Review.
-
A site on factor XII required for productive interactions with polyphosphate.J Thromb Haemost. 2023 Jun;21(6):1567-1579. doi: 10.1016/j.jtha.2023.02.014. Epub 2023 Mar 1. J Thromb Haemost. 2023. PMID: 36863563 Free PMC article.
-
A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation.J Biol Chem. 2020 Jan 10;295(2):363-374. doi: 10.1074/jbc.RA119.009788. Epub 2019 Nov 26. J Biol Chem. 2020. PMID: 31771982 Free PMC article.
-
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis.Semin Thromb Hemost. 2024 Oct;50(7):989-997. doi: 10.1055/s-0043-57011. Epub 2023 Apr 12. Semin Thromb Hemost. 2024. PMID: 37044117 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources